Efficacy of adjunctive ablation of complex fractionated atrial electrograms and pulmonary vein isolation for the treatment of atrial fibrillation: A meta-analysis of randomized controlled trials

Europace

Volumn 13, Issue 2, 2011, Pages 193-204

  Kong, Melissa H ^a   Piccini, Jonathan P ^a,b   Bahnson, Tristram D ^a,b,c  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^c DUKE UNIVERSITY   (United States)

Author keywords

Atrial fibrillation; Catheter ablation; Complex fractionated electrograms; Meta analysis; Pulmonary vein isolation

Indexed keywords

ARTICLE; CATHETER ABLATION; CLINICAL EFFECTIVENESS; ELECTROGRAPHY; FLUOROSCOPY; FOLLOW UP; HEART ATRIUM FIBRILLATION; HUMAN; META ANALYSIS; PERICARDIAL EFFUSION; PERICARDITIS; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; PULMONARY VEIN ISOLATION; PULMONARY VEIN OBSTRUCTION; RADIOFREQUENCY; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW; VASCULAR DISEASE;

ATRIAL FIBRILLATION; CATHETER ABLATION; ELECTROPHYSIOLOGIC TECHNIQUES, CARDIAC; HUMANS; PULMONARY VEINS; TREATMENT OUTCOME;

EID: 79251517792     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/euq384     Document Type: Article

References (39)

1. Gjesdal K, Vist GE, Bugge E, Rossvoll O, Johansen M, Norderhaug I et al. Curative ablation for atrial fibrillation: a systematic review. Scand Cardiovasc J 2008;42:3-8.
2. Nair GM, Nery PB, Diwakaramenon S, Healey JS, Connolly SJ, Morillo CA. A sys-tematic review of randomized trials comparing radiofrequency ablation with anti-arrhythmic medications in patients with atrial fibrillation.J Cardiovasc Electrophysiol 2009;20:138-44.
3. Noheria A, Kumar A, Wylie JV Jr, Josephson ME. Catheter ablation vs anti-arrhythmic drug therapy for atrial fibrillation: a systematic review. Arch Intern Med 2008;168:581-6.
4. Piccini JP, Lopes RD, Kong MH, Hasselblad V, Jackson K, Al-Khatib SM. Pulmonary vein isolation for the maintenance of sinus rhythm in patients with atrial fibrilla-tion: a meta-analysis of randomized, controlled trials. Circ Arrhythm Electrophysiol 2009;2:626-33.
5. Jais P, Cauchemez B, Macle L, Daoud E, Khairy P, Subbiah R et al. Catheter abla-tion versus antiarrhythmic drugs for atrial fibrillation: the A4 study. Circulation 2008;118:2498-505.
6. Krittayaphong R, Raungrattanaamporn O, Bhuripanyo K, Sriratanasathavorn C, Pooranawattanakul S, Punlee K et al. A randomized clinical trial of the efficacy of radiofrequency catheter ablation and amiodarone in the treatment of sympto-matic atrial fibrillation. J Med Assoc Thai 2003;86(Suppl. 1):S8-16.
7. Oral H, Pappone C, Chugh A, Good E, Bogun F, Pelosi F Jr et al.Circumferential pulmonary-vein ablation for chronic atrial fibrillation. N Engl J Med 2006;354: 934-41.
8. Pappone C, Augello G, Sala S, Gugliotta F, Vicedomini G, Gulletta S et al. A ran-domized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: the APAF Study. J Am Coll Cardiol 2006;48:2340-7.
9. Stabile G, Bertaglia E, Senatore G, De Simone A, Zoppo F, Donnici G et al. Cath-eter ablation treatment in patients with drug-refractory atrial fibrillation: a pro-spective, multi-centre, randomized, controlled study (Catheter Ablation For The Cure Of Atrial Fibrillation Study). Eur Heart J 2006;27:216-21.
10. Wazni OM, Marrouche NF, Martin DO, Verma A, Bhargava M, Saliba W et al. Radiofrequencyablation vs antiarrhythmic drugs as first-line treatment of sympto-matic atrial fibrillation: a randomized trial.JAMA 2005;293:2634-40.
11. Arruda M, Natale A. Ablation of permanent AF: adjunctive strategies to pulmon-ary veins isolation: targeting AF NEST in sinus rhythm and CFAE in AF. J Interv Card Electrophysiol 2008;23:51-7.
12. Nademanee K, McKenzie J, Kosar E, Schwab M, Sunsaneewitayakul B, Vasavakul T et al. A new approach for catheter ablation of atrial fibrillation: mapping of the electrophysiologic substrate.JAm Coll Cardiol 2004;43:2044-53.
13. Oral H, Chugh A, Good E, Wimmer A, Dey S, Gadeela N et al. Radiofrequency catheter ablation of chronic atrialfibrillation guided by complex electrograms. Circulation 2007;115:2606-12.
14. Nademanee K, Schwab MC, Kosar EM, Karwecki M, Moran MD, Visessook N et al. Clinical outcomes of catheter substrate ablation for high-risk patients with atrial fibrillation.J Am Coll Cardiol 2008;51:843-9.
15. Haissaguerre M, Sanders P, Hocini M, Takahashi Y, Rotter M, Sacher F et al. Cath-eter ablation of long-lasting persistent atrial fibrillation: critical structures for ter-mination. J Cardiovasc Electrophysiol 2005;16:1125-37.
16. Verma A, Novak P, Macle L, Whaley B, Beardsall M, Wulffhart Z et al. A prospec-tive, multicenter evaluation of ablating complex fractionated electrograms (CFEs) during atrial fibrillation (AF) identified by an automated mapping algorithm: acute effects on AF and efficacy as an adjuvant strategy. Heart Rhythm 2008;5:198-205.
17. Porter M, Spear W, Akar JG, Helms R, Brysiewicz N, Santucci P et al. Prospective study of atrial fibrillation termination during ablation guided by automated detec-tion of fractionated electrograms. J Cardiovasc Electrophysiol 2008;19:613-20.
18. Lin YJ, Tai CT, Chang SL, Lo LW, Tuan TC, Wongcharoen W et al. Efficacy of additional ablation of complex fractionated atrial electrograms for catheter abla-tion of nonparoxysmal atrial fibrillation. J Cardiovasc Electrophysiol 2009;20: 607-15.
19. Estner HL, Hessling G, Ndrepepa G, Luik A, Schmitt C, Konietzko A et al. Acute effects and long-term outcome of pulmonary vein isolation in combination with electrogram-guided substrate ablation for persistent atrial fibrillation. Am J Cardiol 2008;101:332-7.
20. Schmitt C, Estner H, Hecher B, Luik A, Kolb C, Karch M et al. Radiofrequency ablation of complex fractionated atrial electrograms (CFAE): preferential sites of acute termination and regularization in paroxysmal and persistent atrial fibrilla-tion. J Cardiovasc Electrophysiol 2007;18:1039-46.
21. Deisenhofer I, Estner H, Reents T, Fichtner S, Bauer A, Wu J et al. Does electro-gram guided substrate ablation add to the success of pulmonaryvein isolation in patients with paroxysmal atrial fibrillation? A prospective, randomized study. J Cardiovasc Electrophysiol 2009;20:514-21.
22. Di Biase L, Elayi CS, Fahmy TS, Martin DO, Ching CK, Barrett C et al. Atrial fibril-lation ablation strategies for paroxysmal patients: randomized comparison between different techniques. Circ Arrhythm Electrophysiol 2009;2:113-9.
23. Elayi CS, Verma A, Di Biase L, Ching CK, Patel D, Barrett C et al. Ablation for longstanding permanent atrial fibrillation: results from a randomized study com-paring three different strategies. Heart Rhythm 2008;5:1658-64.
24. Oral H, Chugh A, Yoshida K, Sarrazin JF, Kuhne M, Crawford T et al. A random-ized assessment of the incremental role of ablation of complex fractionated atrial electrograms after antral pulmonary vein isolation for long-lasting persistent atrial fibrillation.JAm Coll Cardiol 2009;53:782-9.
25. Verma A, Mantovan R, Macle L, De Martino G, Chen J, Morillo CA et al. Substrate and Trigger Ablation for Reduction ofAtrial Fibrillation (STAR AF): a randomized, multicentre, international trial. Eur Heart J 2010;31:1344-56.
26. Der Simonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7: 177-88.
27. Kirchhof P, Auricchio A, Bax J, Crijns H, Camm J, Diener HC et al. Outcome par-ameters for trials in atrial fibrillation: executive summary. Eur Heart J 2007;28: 2803-17.
28. Calkins H, Brugada J, Packer DL, Cappato R, Chen SA, Crijns HJ et al. HRS/EHRA/ECAS expert Consensus Statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) Task Force on catheter and surgical ablation of atrial fibrillation. Heart Rhythm 2007;4:816-61.
29. Khaykin Y, Skanes A, Champagne J, Themistoclakis S, Gula L, Rossillo A et al. A randomized controlled trial of the efficacy and safety of electroanatomic cir-cumferential pulmonary vein ablation supplemented by ablation of complex frac-tionated atrial electrograms versus potential-guided pulmonary vein antrum isolation guided by intracardiac ultrasound. Circ Arrhythm Electrophysiol 2009;2: 481-87.
30. Oral H, Chugh A, Lemola K, Cheung P, Hall B, Good E et al. Noninducibility of atrial fibrillation as an end point of left atrial circumferential ablation for paroxys-mal atrial fibrillation: a randomized study. Circulation 2004;110:2797-801.
31. Ndrepepa G. Standardization of criteria used in automated algorithms for detec-tion of fractionated electrograms to guide substrate-based ablation ofatrial fibril-lation: no rest for the wicked. Heart Rhythm 2008;5:1142-3.
32. Aizer A, Holmes DS, Garlitski AC, Bernstein NE, Smyth-Melsky JM, Ferrick AM et al. Standardization and validation of an automated algorithm to identify frac-tionation as a guide for atrial fibrillation ablation. Heart Rhythm 2008;5:1134-41.
33. Park JH, Pak HN, Kim SK, Jang JK, Choi JI, Lim HE et al. Electrophysiologic charac-teristics of complex fractionated atrial electrograms in patients with atrial fibrilla-tion. J Cardiovasc Electrophysiol 2009;20:266-72.
34. Rostock T, Rotter M, Sanders P, Takahashi Y, Jais P, Hocini M et al. High-density activation mapping of fractionated electrograms in the atria of patients with par-oxysmal atrial fibrillation. Heart Rhythm 2006;3:27-34.
35. Fazel R, Krumholz HM, Wang Y, Ross JS, Chen J, Ting HH et al. Exposure to low-dose ionizing radiation from medical imaging procedures. N Engl J Med 2009;361:849-57.
36. Nademanee K, Oketani N. The role of complex fractionated atrial electrograms in atrial fibrillation ablation moving to the beat of a different drum. J Am Coll Cardiol 2009;53:790-1.
37. National Research Council. Health Risks from Exposure to Low Levels ofIonizing Radi-ation: BEIR VII Phase 2. Washington, DC: National Academies Press; 2006.
38. Little MP, Tawn EJ, Tzoulaki I, Wakeford R, Hildebrandt G, Paris F et al. Review and meta-analysis of epidemiological associations between low/moderate doses of ionizing radiation and circulatory disease risks, and their possible mechanisms. Radiat Environ Biophys 2010;49:139-53.
39. Fuster V, Ryden LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA et al. ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Com-mittee for Practice Guidelines (Writing Committee to Revisethe 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collabor-ation with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 2006;114:e257-354.